RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity

Hu, X., Moisan, J., Majchrzak, K., Lesch, C., Wang, Y., Sanchez, B., … Carter, L. (2015). RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. Journal for ImmunoTherapy of Cancer, 3(S2). https://doi.org/10.1186/2051-1426-3-s2-p23